News

The Lum.AI team (from left): Marco Antonio Valenzuela-Escárcega, PhD, Gustave Hahn-Powell and Mihai Surdeanu, PhD. Photo credit: Paul Tumarkin/Tech Launch Arizona.

The Lum.AI team (from left): Marco Antonio Valenzuela-Escárcega, PhD, Gustave Hahn-Powell and Mihai Surdeanu, PhD. Photo credit: Paul Tumarkin/Tech Launch Arizona.

Wednesday, November 29, 2017

For a researcher, developing a holistic understanding of a field is an immense task. UA inventors have devised an automated system to extract information from literature and generate easily interpretable answers. Now, the UA has licensed it to their startup, Lum.AI.

Rongguang Liang, PhD, College of Optical Sciences (left), received funding to develop 3-D printing of freeform optics. Pictured here with graduate student and co-inventor Zhihan Hong (right). Photo credit: Paul Tumarkin/Tech Launch Arizona

Rongguang Liang, PhD, College of Optical Sciences (left), received funding to develop 3-D printing of freeform optics. Pictured here with graduate student and co-inventor Zhihan Hong (right). Photo credit: Paul Tumarkin/Tech Launch Arizona

Tuesday, November 28, 2017

The goal of commercialization is to get the products of research out into the world for the public good. Asset Development funding helps develop early-stage technologies and make them more attractive for market adoption. The program is generating opportunities – and results.

Bruce Wright receives the 2017 Executive Excellence Award presented by Tucson Local Media and Inside Tucson Business. Photo credit: Jessa Turner/Tech Parks Arizona

Bruce Wright receives the 2017 Executive Excellence Award presented by Tucson Local Media and Inside Tucson Business. Photo credit: Jessa Turner/Tech Parks Arizona

Friday, November 3, 2017

UA Associate Vice President Bruce Wright received the COO/Leadership Equivalent Award for a non-profit organization during the 2017 Executive Excellence Award presented by Tucson Local Media and Inside Tucson Business.

FY2017 Annual Report Now Available
Tuesday, October 31, 2017

Download the FY2017 Annual Report and review our progress against our 2020 vision and our metrics, the achievements of Tech Parks Arizona, and the big picture of the growth of the culture of commercialization throughout the University of Arizona ecosystem.

Drs. May and Rajesh Khanna, inventors of the non-opioid drug candidates.

Drs. May and Rajesh Khanna, inventors of the non-opioid drug candidates.

Monday, October 30, 2017

At a time when opioid addiction represents a major public health crisis, researchers in the UA College of Medicine – Tucson have invented a new class of non-opioid drug candidates to treat pain. The University has licensed the compounds to startup Regulonix. 

The Reglagene team, from left: Dr. Laurence Hurley, Dr. Vijay Gokhale and Dr. Richard Austin. Photo credit: Paul Tumarkin/Tech Launch Arizona

The Reglagene team, from left: Dr. Laurence Hurley, Dr. Vijay Gokhale and Dr. Richard Austin. Photo credit: Paul Tumarkin/Tech Launch Arizona

Friday, October 27, 2017

The UA has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology, invented at the UA College of Pharmacy and the BIO5 Institute by Laurence Hurley, PhD, and Vijay Gokhale, PhD, has been shown to be effective in inducing cancer cells to grow old and die.

Alzheimer's disease plaques. Image courtesy of ProNeurogen.

Alzheimer's disease plaques. Image courtesy of ProNeurogen.

Wednesday, October 25, 2017

UA College of Medicine – Tucson Professor Meredith Hay, PhD, and her colleagues started ProNeurogen to commercialize their inventions in neuroscience and cardiovascular neurophysiology. The UA has been awarded two patents for their approach to treating memory loss and cognitive impairment.

UAVentures will be located in downtown Tucson in the historic Rondstadt House.

UAVentures will be located in downtown Tucson in the historic Rondstadt House. Photo credit: Ammodramus/Wikimedia Commons

Thursday, September 28, 2017

UAVenture Capital, LLC has announced the launch of a fund to support the commercialization of University of Arizona science, services and intellectual property. UAVC was formed by Fletcher J. McCusker, the business driver behind the UA College of Pharmacy startup SinfoníaRx.

Kelle Hyland and Amy Randall of the BIO5 Institute talk with BIO5 Interim Director Jennifer Barton at the UA booth at AZBio 2016, the state's premier annual bioindustry event. Photo credit: Mark Goldstein

Kelle Hyland and Amy Randall of the BIO5 Institute talk with BIO5 Interim Director Jennifer Barton at the UA booth at AZBio 2016, the state's premier annual bioindustry event. Photo credit: Mark Goldstein

Wednesday, September 6, 2017

In October, the Arizona Bioindustry Association, or AZBio, will honor industry leaders from across Arizona. This year, a majority of those to be honored have deep connections to the UA and have created impact through bringing UA ideas and inventions to the marketplace. 

SinfoníaRx President Kevin Boesen and CEO Fletcher McCusker at TLA's first awards event in 2014. Photo credit: Paul Tumarkin/Tech Launch Arizona

SinfoníaRx President Kevin Boesen and CEO Fletcher McCusker at TLA's first awards event in 2014. Photo credit: Paul Tumarkin/Tech Launch Arizona

Wednesday, September 6, 2017

UA startup SinfoníaRx has been acquired by Tabula Rasa HealthCare (NASDAQ: TRHC), provider of individualized, data-driven technology solutions. Spun out of the College of Pharmacy in 2013, SinfoníaRx pioneered modern medication therapy management (MTM) services.

Pages